BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 32445173)

  • 21. Expression of leptin and its receptor in thyroid carcinoma: distinctive prognostic significance in different subtypes.
    Fan YL; Li XQ
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):261-7. PubMed ID: 25158596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid anaplastic carcinoma: the impact of multimodality treatment on survival. The experience of a referral center for endocrine surgery.
    Polistena A; Monacelli M; Lucchini R; Triola R; Conti C; Avenia S; Sole Di Patrizi M; Barillaro I; Boccolini A; Sanguinetti A; Avenia N
    Minerva Chir; 2014 Oct; 69(5):261-9. PubMed ID: 25052058
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Case Report: 84-Month Disease-Free Survival after Surgery for Anaplastic Thyroid Carcinoma.
    Kanazawa S; Kammori M
    J Nippon Med Sch; 2019; 86(1):38-42. PubMed ID: 30918155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
    Jannin A; Giudici F; de la Fouchardière C; Al Ghuzlan A; Wassermann J; Chougnet CN; Drui D; Godbert Y; Ilouz F; Bardet S; Zanetta S; Roudaut N; Batisse Lignier M; Groussin L; Klein M; Zerdoud S; Lamartina L; Baudin E; Decaussin-Petrucci M; Leteurtre E; Borson Chazot F; Do Cao C; Borget I; Hadoux J;
    Thyroid; 2023 Oct; 33(10):1190-1200. PubMed ID: 37855745
    [No Abstract]   [Full Text] [Related]  

  • 25. Anaplastic thyroid carcinoma: a 25-year single-institution experience.
    Mohebati A; Dilorenzo M; Palmer F; Patel SG; Pfister D; Lee N; Tuttle RM; Shaha AR; Shah JP; Ganly I
    Ann Surg Oncol; 2014 May; 21(5):1665-70. PubMed ID: 24554064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of surgery in the management of anaplastic thyroid carcinoma: Korean nationwide multicenter study of 329 patients with anaplastic thyroid carcinoma, 2000 to 2012.
    Baek SK; Lee MC; Hah JH; Ahn SH; Son YI; Rho YS; Chung PS; Lee YS; Koo BS; Jung KY; Lee BJ
    Head Neck; 2017 Jan; 39(1):133-139. PubMed ID: 27534388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radiotherapy Plus Chemotherapy Leads to Prolonged Survival in Patients With Anaplastic Thyroid Cancer Compared With Radiotherapy Alone Regardless of Surgical Resection and Distant Metastasis: A Retrospective Population Study.
    Zhou W; Yue Y; Zhang X
    Front Endocrinol (Lausanne); 2021; 12():748023. PubMed ID: 34790169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
    Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
    Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
    Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
    Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.
    Fan D; Ma J; Bell AC; Groen AH; Olsen KS; Lok BH; Leeman JE; Anderson E; Riaz N; McBride S; Ganly I; Shaha AR; Sherman EJ; Tsai CJ; Kang JJ; Lee NY
    Cancer; 2020 Jan; 126(2):444-452. PubMed ID: 31593317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
    Pezzi TA; Mohamed ASR; Sheu T; Blanchard P; Sandulache VC; Lai SY; Cabanillas ME; Williams MD; Pezzi CM; Lu C; Garden AS; Morrison WH; Rosenthal DI; Fuller CD; Gunn GB
    Cancer; 2017 May; 123(9):1653-1661. PubMed ID: 28026871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multimodality Treatment Improves Locoregional Control, Progression-Free and Overall Survival in Patients with Anaplastic Thyroid Cancer: A Retrospective Cohort Study Comparing Oncological Outcomes and Morbidity between Multimodality Treatment and Limited Treatment.
    Jonker PKC; Turchini J; Kruijff S; Lin JF; Gill AJ; Eade T; Aniss A; Clifton-Bligh R; Learoyd D; Robinson B; Tsang V; Glover A; Sidhu S; Sywak M
    Ann Surg Oncol; 2021 Nov; 28(12):7520-7530. PubMed ID: 34032961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Factors and Survival Score for Patients With Anaplastic Thyroid Carcinoma: A Retrospective Study from a Regional Registry.
    Marchand-Crety C; Pascard M; Debreuve-Theresette A; Ettalhaoui L; Schvartz C; Zalzali M; Brugel M; Bellefqih S; Servagi-Vernat S
    Anticancer Res; 2021 Mar; 41(3):1555-1561. PubMed ID: 33788749
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
    Roche AM; Fedewa SA; Shi LL; Chen AY
    Cancer; 2018 Apr; 124(8):1780-1790. PubMed ID: 29409119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in
    Wang JR; Zafereo ME; Dadu R; Ferrarotto R; Busaidy NL; Lu C; Ahmed S; Gule-Monroe MK; Williams MD; Sturgis EM; Goepfert RP; Gross ND; Lai SY; Gunn GB; Phan J; Rosenthal DI; Fuller CD; Morrison WH; Iyer P; Cabanillas ME
    Thyroid; 2019 Aug; 29(8):1036-1043. PubMed ID: 31319771
    [No Abstract]   [Full Text] [Related]  

  • 36. Anaplastic Transformation of Differentiated Thyroid Carcinoma.
    Yu AC; Han AY; Cronkite DA; Sajed D; St John MA
    Laryngoscope; 2023 Feb; 133(2):437-442. PubMed ID: 35779253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Age Influences the Prognosis of Anaplastic Thyroid Cancer Patients.
    Kong N; Xu Q; Zhang Z; Cui A; Tan S; Bai N
    Front Endocrinol (Lausanne); 2021; 12():704596. PubMed ID: 34385977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A relook at the 8th edition of the AJCC TNM staging system of anaplastic thyroid carcinoma: A SEER-based study.
    Xiang J; Wang Z; Sun W; Zhang H
    Clin Endocrinol (Oxf); 2021 Apr; 94(4):700-710. PubMed ID: 33368530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare Manifestations of Anaplastic Thyroid Carcinoma: the Role of BRAF Mutation Analysis.
    Song YS; Jung CK; Jung KC; Park YJ; Won JK
    J Korean Med Sci; 2017 Oct; 32(10):1721-1726. PubMed ID: 28875621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational profiling of poorly differentiated and anaplastic thyroid carcinoma by the use of targeted next-generation sequencing.
    Duan H; Li Y; Hu P; Gao J; Ying J; Xu W; Zhao D; Wang Z; Ye J; Lizaso A; He Y; Wu H; Liang Z
    Histopathology; 2019 Dec; 75(6):890-899. PubMed ID: 31230400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.